# Nuclide record paper-strosberg-netter1-qol-jco-2018 (paper). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/key-papers/paper-strosberg-netter1-qol-jco-2018/>
  a schema:ScholarlyArticle ;
  nuclide:kind "paper" ;
  schema:identifier "paper-strosberg-netter1-qol-jco-2018" ;
  schema:name "Health-related quality of life in the NETTER-1 trial of 177Lu-Dotatate"@en ;
  schema:description "In people with a slow-growing gut cancer, the radioactive treatment lutetium-177 dotatate did not just shrink tumours for longer - it also kept their day-to-day quality of life, including energy, pain and diarrhoea, better for much longer than the older drug it was compared with."@en ;
  schema:url <https://nuclide.cc/key-papers/paper-strosberg-netter1-qol-jco-2018/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/29878866/>, <https://ascopubs.org/doi/10.1200/JCO.2018.78.5865> ;
  nuclide:tag "neuroendocrine tumours", "PRRT", "quality of life" ;
  schema:sameAs <https://doi.org/10.1200/JCO.2018.78.5865> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Strosberg J, Wolin E, Chasen B, Kulke M, Bushnell D, et al." ;
  nuclide:related <https://nuclide.cc/trials/netter-1/>, <https://nuclide.cc/key-papers/paper-netter-1-nejm-2017/>, <https://nuclide.cc/drugs/lutathera/>, <https://nuclide.cc/technologies/prrt/>, <https://nuclide.cc/indications/small-intestinal-net/>, <https://nuclide.cc/people/jonathan-strosberg/>, <https://nuclide.cc/people/richard-baum/>, <https://nuclide.cc/isotopes/lu-177/> .